Introduction: Children with neuromuscular diseases develop cough impairment.
(DMD) and congenital myopathies or muscular dystrophies may be complicated by weak cough and increased susceptibility to recurrent respiratory tract infections (RTIs). This is a major cause of morbidity and mortality [1] [2] [3] and various care guidelines, therefore, advise early start of airway clearance techniques (ACTs) to prevent RTIs. [4] [5] [6] Airstacking (AS) is probably the most accepted form of ACT in the Netherlands, but mechanical insufflation-exsufflation (MI-E) is used increasingly despite the fact that evidence for efficacy, especially in children, is scarce. 5, 7 We identified only one randomized controlled trial that compared the effect of MI-E and AS on frequency of RTIs among patients with amyotrophic lateral sclerosis, showing a trend towards better outcome for MI-E. 8 Experts prefer to use MI-E in very weak patients, those who cannot cooperate with AS and MAC, or in whom these techniques are not effective. 4 Recently, a consensus meeting of the European Neuromuscular Center concluded that the clinician can decide on what ACT to use, depending on forced vital capacity (FVC) and peak cough flow (PCF), but also on local availability, efficacy, tolerance, and preference. 5 MI-E was introduced in The Netherlands in 2005, but the lack of evidence for its efficacy has hampered reimbursement arrangements with health insurance companies. The aim of this study was to retrospectively analyze the number of hospital admissions and admission days due to RTIs before and after initiation of MI-E in a large singlecenter cohort of children. Our second aim was to prospectively evaluate patient and caregiver experience and burden of MI-E use by using a questionnaire. We hypothesized that the number of RTIs requiring hospital admission would decrease after the introduction of MI-E and that patient satisfaction would be high.
| MATERIALS AND METHODS

Our center for home ventilation at the University Medical Center (UMC)
Utrecht welcomes 131 children, approximately half of the pediatric patients in the Netherlands who need ventilation. We included all children (n = 37) who had started daily MI-E at home. According to our protocol patients with reduced PCF for age or recurrent RTIs start regular ACT at home by means of AS twice daily. 4, 5, 9 When technique (eg, due to young age) or efficacy are insufficient, we switch to MI-E using Philips Respironics CoughAssist or Philips Cough Assist E70. Settings are individualized to optimize airway clearance using maximum tolerable pressures up to 40 cmH 2 O. We teach caregivers to perform three cycles, each with 5 in-and exsufflations, at a frequency of at least twice a day and more frequently during RTIs. We evaluated all medical files systematically for admissions before and after initiation of MI-E. We contacted Pediatric Intensive Care Units (PICUs) in the other University Hospitals in The Netherlands to check for additional admissions. We collected patient data from birth until 1st of June 2019. In addition, we approached parents or legal guardians of all included study participants to explore their experiences and burden regarding MI-E use, using a questionnaire with answers on Likert scales. 
| DISCUSSION
This retrospective study suggests that the treatment of children with severe NMDs with MI-E may lead to a decrease in the number of RTIs requiring admission and shorter hospital stays. Patients or their caregivers experienced important benefits with low burden. This is, to the best of our knowledge the first study exploring the possible effects of the introduction of MI-E on the incidence of RTIs requiring admission in children with NMDs. A limited number of previous studies studied the effect of MI-E during RTI. These studies show the reduced need for tracheotomy or intubation, shortening of airwayclearance sessions, shortened duration of symptoms of RTI and reduced odds of hospitalization. 8, 10, 11 One study in adult patients with spinal cord injury compared hospitalizations in general (and not only due to RTI), which showed a nonsignificant reduction of respiratory hospitalization rate of 34% after introduction of MI-E. 12 It is our impression that physicians often believe that burden of MI-E is high and that these believes, combined with lack of evidence for efficacy, may delay the introduction of MI-E. However, our data suggest that caregivers and patients experience important benefits and low burden. 
| CONCLUSION
This retrospective cohort study is the first pediatric study which suggests decreased RTI related hospital admission rate and shorter admission duration after the introduction of MI-E. Patient satisfaction was high, with low burden. 
